Register for free to
view the full innovation profile.
Utilising a unique chemical process that selectively targets functional groups on the polypeptide chains, ensuring a high degree of specificity and stability in the conjugation.
About
Background
Bioconjugation, the process of chemically linking two molecules, is essential for developing targeted therapeutics and diagnostics. Traditional methods often face challenges with specificity and efficiency, limiting their clinical and research applications. This new patented method addresses these issues by providing a highly specific and efficient bioconjugation process for polypeptides.
Technology overview
The patented technology involves a novel method for the bioconjugation of polypeptides. It utilises a unique chemical process that selectively targets functional groups on the polypeptide chains, ensuring a high degree of specificity and stability in the conjugation. This method allows for the attachment of various payloads, such as drugs, imaging agents, or other biomolecules, to the polypeptides.
Key Benefits
- High Specificity: Targets specific functional groups on polypeptides, reducing off-target effects.
- Stability: Produces stable conjugates that maintain functionality under physiological conditions.
- Versatility: Compatible with a wide range of payloads, including small molecule drugs, proteins, and imaging agents.
- Efficiency: Enhances the efficiency of the conjugation process, reducing time and resource requirements.
- Scalability: Suitable for large-scale production, facilitating clinical and commercial applications.
Applications
- Targeted Drug Delivery: Enables precise delivery of therapeutic agents to specific cells or tissues.
- Medical Imaging: Facilitates the development of advanced imaging agents for diagnostics.
- Research Tools: Provides reliable conjugates for studying biological processes and interactions.
- Therapeutics: Enhances the development of biopharmaceuticals with improved efficacy and safety profiles.